Page 22 - Contracts And Orders News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Contracts and orders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Contracts And Orders Today - Breaking & Trending Today

NBS Capital Inc. Completes Subscription Receipt Financing for Aggregate Proceeds of $5 Million

Press release content from Accesswire. The AP news staff was not involved in its creation.
NBS Capital Inc. Completes Subscription Receipt Financing for Aggregate Proceeds of $5 Million
February 18, 2021 GMT
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWS WIRES
OTTAWA, ON / ACCESSWIRE / February 18, 2021 / NBS Capital Inc. (“NBS” or the “Company”) (TSXV:NBS.P) announces further to its press release of January 4, 2021, that in connection with its proposed scheme of arrangement (the “Arrangement”) with Electric Metals (USA) Limited (“EML”), EML and NBS have completed the non-brokered private placements (the “Financing”) of subscription receipts (the “Subscription Receipts”) in multiple tranches for aggregate gross proceeds of Cdn$5,049,635.13, at a price of Cdn$0.33 per Subscription Receipt. Pursuant to the fully subscribed Financing, EML issued a total of 13,308,407 Subscription Receipts for proceeds of Cdn$4,391,774.85, and N ....

United States , Corcoran Canyon , Paul Barbeau , Company The Escrow Agent , Capital Inc , Metals United States , Exchange Requirements , Metals United States Limited , Regulation Services Provider , Venture Exchange , Electric Metals , Subscription Receipt , Escrow Release Conditions , Termination Date , Underlying Warrant , Resulting Issuer , Warrant Expiry Date , Underlying Share , Proposed Transaction , Escrowed Funds , Canyon Silver Project , Escrow Agent , Release Notice , Subscription Receipts , Subscription Price , Arrangement Agreement ,

ClearPoint Neuro, Inc. Announces License and Research Agreement with Philips

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
ClearPoint Neuro, Inc. Announces License and Research Agreement with Philips
ClearPoint Neuro, Inc.February 18, 2021 GMT
Collaboration will Enable ClearPoint to Develop and Launch the ClearPoint ‘Maestro™’ Brain Model by 2022
IRVINE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced a worldwide license and research agreement with Philips, a global leader in health technology, to commercialize the ClearPoint ‘Maestro’ Brain Model. The company expects the first-generation anatomical segment analysis tool to be launched in 2022. ....

United States , Joe Burnett , Jacqueline Keller , Erik Pastink , Company Clearpoint Neuro Navigation System , Clearpoint Neuro Inc , Company Annual Report On Form , Exchange Commission , Applications Of The Company , Company Quarterly Report On Form , Company Smartflow , Program Leader Healthtech Ip Licensing At Philips , Enable Clearpoint , Brain Model , Point Neuro , Maestro Brain , Program Leader Healthtech , Clearpoint Neuro , Philips Brain Model , Clearpoint Neuro Navigation System , Annual Report , Quarterly Report , Vice President , Licensing Agreements , Corporate News , Covid 19 Pandemic ,

BK Technologies Receives Order from a Municipality in Montana For New BKR 5000 Portable Communications Technology for First Responders

Press release content from Accesswire. The AP news staff was not involved in its creation. ....

West Melbourne , United States , Tim Vitou , Company Annual Report On Form , Company Contact , Bk Technologies Corporation , Line Of Communications Technology Incorporating Multi , New Line , Public Safety , Private Securities Litigation Reform Act , Annual Report , Government Business And Finance , Products And Services , Coronavirus Pandemic , Government Contracts , Lung Disease , Covid 19 Pandemic , Infectious Diseases , Contracts And Orders , Corporate Stock , Corporate News , North America , Diseases And Conditions , Government And Politics , New Products And Services , மேற்கு மெல்போர்ன் ,

Tribune Publishing to be Acquired by Alden Global Capital

Press release content from PR Newswire. The AP news staff was not involved in its creation.
Tribune Publishing to be Acquired by Alden Global Capital
February 16, 2021 GMT
CHICAGO, Feb. 16, 2021 /PRNewswire/ Tribune Publishing Company (NASDAQ: TPCO) (“Tribune” or the “Company”) and affiliates of Alden Global Capital (“Alden”) today announced that they have entered into a definitive merger agreement under which Alden will acquire all of the outstanding shares of Tribune common stock not currently owned by Alden for $17.25 per share in cash. Alden currently owns 11,554,306 shares of Tribune common stock, representing 31.6% of the Company’s outstanding shares.
The purchase price represents a premium of 45% to the closing price of Tribune common stock on December 11, 2020, the last trading day prior to receiving Alden’s proposal, a premium of approximately 35% to the closing price of Tribune common stock on December 30, 2020, the last trading day prio ....

New York , United States , Stewart Bainum Jr , Philipg Franklin , Max Reinsdorf , Amy Bullis , Davidson Goldin , Tribune Enterprises , Akin Gump Strauss Hauer Feld , Tribune Publishing Company , Moelis Company , New York Daily News , Virginia Daily , Davis Polk Wardwell , Chicago Tribune , Tribune Content Agency , Exchange Commission , Baltimore Sun To Sunlight For All Institute , Prnewswire Tribune Publishing Company , Securities Exchange , Baltimore Sun , Publishing Company , Alden Global Capital , All Institute , Stewart Bainum , Hart Scott Rodino Antitrust Improvements Act ,

Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®

Press release content from Business Wire. The AP news staff was not involved in its creation.
Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®
February 17, 2021 GMT
NEW YORK & MAINZ, Germany (BUSINESS WIRE) Feb 17, 2021
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced an agreement with the European Commission (EC) to supply an additional 200 million doses of COMIRNATY ®, the companies’ COVID-19 Vaccine, to the 27 European Union (EU) member states. The EC has the option to request supply of an additional 100 million doses.
ADVERTISEMENT
This new agreement is in addition to the 300 million doses that have already been committed to the EU through 2021 under the first supply agreement signed last year. The additional 200 million doses are expected to be delivered in 2021, with an estimated 75 million to be supplied in the second quarter. ....

United States , United Kingdom , Sylke Maas , Albert Bourla , Chuck Triano , Andrew Widger , Ugur Sahin , Fosun Pharma , Centers For Disease , European Commission , Drug Administration , Bayer Animal Health , Exchange Commission , Pfizer Inc , European Union , Roche Group , Vaccine Administration Under Emergency Use Authorization , Chief Executive Officer , Marketing Authorizations Holder , Emergency Use Authorization , Coronavirus Disease , Fact Sheet , Healthcare Providers Administering Vaccine , Vaccination Providers , Disease Control , Adverse Events ,